Key facts
- Notable investors include Legend Capital, SJ Jiacheng Investment Management, Chengdu Bio-Town Investment.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Zhenyu Biotechnology
- ·The full record, as it builds
Funding rounds
No funding rounds for Zhenyu Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Zhenyu Biotechnology
Manufacturer of advanced biopharmaceutical technologies intended to create innovative immunotherapies and cell-based treatments for complex diseases. The company offers universal therapeutic cell vaccines and in vivo CAR-T platforms, enabling oncology researchers and healthcare providers to access effective, safe, and accessible next-generation therapies.
- Sector
- Healthcare
- HQ
- Chengdu, China
- Founded
- 2023
- Ownership
- Privately Held (backing)
Zhenyu Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Zhenyu Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Zhenyu Biotechnology in its N-PORT filings yet. We sweep new filings monthly.